Analysts at BofA/Merrill upgrade DENTSPLY International Inc XRAY from “neutral” to “buy.” The target price for XRAY is set to $40.
XRAY shares gained 6.48% to $37.61 in pre-market trading.
More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
